for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-GW Pharma Says Mid Stage Study Of Seizures Drug Failed Main Goal

Feb 21 (Reuters) - GW Pharmaceuticals Plc:

* GW PHARMACEUTICALS ANNOUNCES PRELIMINARY RESULTS OF PHASE 2A STUDY FOR ITS PIPELINE COMPOUND GWP42006

* GW PHARMA - PHASE 2A PROOF OF CONCEPT STUDY OF A PIPELINE COMPOUND GWP42006 IN ADULT PATIENTS WITH FOCAL SEIZURES DID NOT MEET ITS PRIMARY ENDPOINT Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up